This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Maty Tzukerman: Innovator in Stem Cell Research
Introduction
Maty Tzukerman is a notable inventor based in Hagetaot, IL. She has made significant contributions to the field of stem cell research, particularly in the development of multicellular compositions that combine pluripotent human embryonic stem cells with cancer cells. Her work is pivotal in understanding cancer cell behavior within a normal human tissue microenvironment.
Latest Patents
Tzukerman holds a patent for "Multicellular compositions of pluripotent human embryonic stem cells and cancer cells." This patent outlines methods for producing novel multicellular compositions that are capable of proliferating and differentiating into various normal cell lines and tissue structures. These compositions are instrumental for investigating the properties of cancer cells and for studying interventions that can modulate these properties, including the development and testing of therapeutic drugs. She has 1 patent to her name.
Career Highlights
Maty Tzukerman is associated with the Technion Research & Development Foundation Ltd., where she continues her research and innovation in the field of stem cells and cancer. Her work has garnered attention for its potential applications in therapeutic drug development and cancer treatment.
Collaborations
Tzukerman collaborates with Karl L Skorecki, who is also a prominent figure in the field of stem cell research. Their partnership enhances the research efforts and contributes to advancements in understanding cancer biology.
Conclusion
Maty Tzukerman's innovative work in stem cell research and her patent on multicellular compositions highlight her contributions to the scientific community. Her research has the potential to lead to significant advancements in cancer treatment and therapeutic interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
